Analogues of the novel inhibitor of the PI3-K/PKB pathway, 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate (E1), have been prepared and preliminary SAR performed. This established that at least one of the chloroethyl para-substituents could be removed or modified and the ability to inhibit PKB/Akt activation retained. Synthetic methodologies were then developed to methylene-linked aryl acetates for use as molecular probes to identify the target of compound E1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmc.2010.06.017 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!